West Pharmaceutical: Remains A Strong Long-Term Prospect

Group 1 - The company West Pharmaceutical Services (NYSE: WST) has experienced a challenging year with noticeable underperformance against the index since May 2024 [1] - The analysis aims to identify high-quality businesses for long-term portfolio creation that can outperform the market [1]